Logo

WORX

SCWorx Corp.

WORX

SCWorx Corp. • NASDAQ
$0.25 ▼ -2.36% (-0.01)
Market Cap $1.02 M
52w High $2.62
52w Low $0.23
Dividend Yield 0%
P/E -0.29
Volume 549.25K
Outstanding Shares 4.10M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $705.799K ▲ $390.784K ▼ $-1.313M ▲ -185.965% ▲ $-0.15 ▲ $2.292M ▲
Q2-2025 $682.632K ▼ $473.944K ▲ $-1.906M ▼ -279.226% ▼ $-0.46 ▼ $-371.631K ▼
Q1-2025 $720.299K ▲ $470.86K ▼ $-476.303K ▼ -66.126% ▼ $-0.25 ▼ $-333.997K ▼
Q4-2024 $675.749K ▼ $538.774K ▲ $-195.29K ▲ -28.9% ▲ $-0.13 ▲ $-152.923K ▲
Q3-2024 $759.724K $526.074K $-424.963K -55.936% $-0.27 $-393.498K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $684.295K ▲ $7.176M ▲ $1.178M ▼ $5.997M ▲
Q2-2025 $340.209K ▼ $6.646M ▼ $1.196M ▼ $5.45M ▼
Q1-2025 $1.072M ▲ $7.157M ▲ $1.563M ▼ $5.594M ▲
Q4-2024 $106.654K ▲ $6.346M ▼ $1.856M ▼ $4.49M ▲
Q3-2024 $87.666K $6.522M $2.038M $4.485M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-1.313M ▲ $-358.08K ▲ $0 $702.166K ▲ $344.086K ▲ $-358.08K ▲
Q2-2025 $-1.906M ▼ $-651.833K ▼ $0 $-80.374K ▼ $-732.207K ▼ $-651.83K ▼
Q1-2025 $-476.303K ▼ $-404.621K ▼ $0 $1.37M ▲ $965.762K ▲ $-404.62K ▼
Q4-2024 $-195.29K ▲ $-134.432K ▲ $0 $153.42K ▼ $18.988K ▼ $-134.43K ▲
Q3-2024 $-424.963K $-362.607K $0 $433.009K $70.402K $-362.61K

Revenue by Products

Product Q1-2018Q2-2018
Athlete Management
Athlete Management
 $0 ▲$0 ▲
Corporate Segment
Corporate Segment
 $0 ▲$0 ▲
Ticket Service Segment
Ticket Service Segment
 $0 ▲$0 ▲
Promotion Segment
Promotion Segment
 $0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement The income statement shows a company that has not yet built a real, visible revenue base over the past several years, while consistently losing money. Reported sales are essentially negligible, suggesting the business is still very early in commercial scale or that most activity is not yet translating into recognized revenue. Losses appear to be recurring, and the earnings per share figures swing sharply from year to year, likely influenced by share count changes and reverse stock splits rather than true profit improvement. Overall, the story here is an unproven revenue engine and a business model that has not demonstrated financial traction yet, with high uncertainty around when or if that will change.

Balance Sheet

Balance Sheet The balance sheet is extremely thin. The company operates with a very small asset base and almost no reported cash, which signals limited financial cushion. On the positive side, there is no meaningful debt reported, so there is no heavy interest burden. However, shareholder equity is also very small and has been edging down, which means there is little buffer to absorb future losses. This combination suggests financial fragility and a likely need to rely on external capital—such as new share issuance—to keep funding operations.

Cash Flow

Cash Flow Reported cash flow data are effectively flat, with no meaningful operating or free cash flow showing up. That usually indicates the business is not yet generating cash from its core operations and is not investing heavily in physical assets either. In practice, a company in this position typically survives through periodic fundraising rather than self-funding its growth. The lack of visible positive cash generation makes the business highly sensitive to capital market conditions and to any delays in signing or expanding customer contracts.

Competitive Edge

Competitive Edge SCWorx occupies a narrow niche in healthcare IT, focusing on cleaning and standardizing complex hospital data—especially supply and item data. Its middleware role and specialized rule engine can create stickiness once installed, because switching providers would be painful for hospitals. This gives the company a real, if narrow, competitive edge. However, it operates in a market with much larger, better-funded players that offer broader analytics and data platforms. SCWorx’s main challenges are its very small scale, limited brand recognition, and dependence on a relatively small number of relationships, which may constrain its ability to compete for large-system deals even if its technology is strong.

Innovation and R&D

Innovation and R&D The company’s core technology—its data normalization engine, virtualized item master, and use of AI and machine learning—appears genuinely differentiated for a very specific problem hospitals face. Being able to integrate with existing hospital systems and act as a data “translator” is a real technical strength. The recent appointment of a new chief technology officer points to a desire to refresh the product roadmap and deepen the AI capabilities. The risk is that limited financial resources can starve R&D and slow innovation just as the broader market is moving quickly in healthcare analytics and automation. Execution on partnerships, new product features, and visible customer success stories will be critical to prove the platform’s relevance over time.

Summary

Overall, WORX looks like a tiny, financially fragile healthcare IT specialist with an interesting niche technology but an unproven business model at scale. The company has carved out a specific problem—cleaning and standardizing hospital item and supply data—and built tools that could generate meaningful value for its clients. At the same time, the financial statements show almost no revenue, ongoing losses, and a very thin capital base, implying heavy dependence on external financing and significant risk if growth does not materialize. The key uncertainties are whether SCWorx can turn its technical strengths and partnerships into steady, growing revenue and whether it can secure enough funding to bridge the gap while doing so. This combination makes the situation highly speculative and very sensitive to execution outcomes.

NEWS

October 14, 2025 · 10:15 AM UTC

SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

Read more

October 6, 2025 · 10:15 AM UTC

SCWorx Renews Agreement with Existing Healthcare Partner for Additional Three Years and 113% Increase in Contract Value

Read more

September 29, 2025 · 9:49 AM UTC

SBA WORX Selects LenderAI as a Technology Platform for Its LSP Business

Read more

September 3, 2025 · 11:44 AM UTC

SCWorx Corp. Appoints New Chief Technology Officer to Accelerate Innovation in Healthcare Data Solutions

Read more